In this CME Outfitters livestream symposium, faculty will examine the role of pro-inflammatory cytokines in the pathogenesis of IBD, discern differences in IL-23 binding among IL-23p19–targeted therapies, assess the safety and efficacy of IL-23p19–targeted therapies for the treatment of IBD, and explore when to incorporate IL-23p19–targeted therapies into the management of patients with IBD.

In this first installment of a CMEO podcast series expert faculty will discuss strategies to identify new and emerging pathological targets, evaluate new and emerging evidence related to these novel targets, and the importance of these targets in treatment decision-making.

In this third installment of a CMEO podcast series expert faculty will discuss strategies to better apply precision medicine to emerging IBD therapies such as TL1A inhibitors as a means of closing gaps in care.

In this CME Outfitters recorded symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.

In this CME Outfitters Infographic, expert faculty will explore the role of new advanced therapies in UC treatment algorithms, facilitating the transition to these therapies in patients with UC who are non-/under-responsive to traditional treatments, and utilizing traditional treatments as well as available biologics and small-molecule therapies to optimize outcomes in patients with IP.

In this CME Outfitters recorded symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with IL-23, the molecular attributes of anti–IL-23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.

In this CME Outfitters recorded symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making. 

In this CME Outfitters recorded symposium led by a multi-disciplinary panel of UC experts, clinicians will learn about the changes happening in the UC treatment landscape, which treatments may offer patients with UC a higher quality of life, and which UC treatments have significant long-term benefit, thus optimizing access to the best treatments available to patients in different stages of disease.

In this CME Outfitters BriefCase, part of a collection on health equity, expert faculty will explore strategies to improve health equity in gastrointestinal care. The focus will be on understanding upstream, midstream, and downstream drivers of health inequities, such as socioeconomic status, immigration status, and lack of social support. Learners will gain actionable strategies, including utilizing case managers, interpreter services, culturally aligned dieticians, and community support workers to address social drivers of health. These strategies aim to improve diagnosis, treatment, and outcomes for underserved populations, fostering equitable gastrointestinal care delivery.

In this CME Outfitters webcast, expert faculty will discuss recognizing the frequency of bowel urgency in patients with CD and the impact to patient QoL, incorporating assessments for bowel urgency as part of thorough symptom evaluation for patients with CD, and engaging patients in open communication about their bowel urgency as part of shared decision-making in order to improve clinical outcomes.

In this CMEO Outfitters recorded symposium, expert faculty discuss recognizing the frequency of bowel urgency in patients with CD and the impact on patient QoL, incorporating assessments for bowel urgency through symptom evaluation, and engaging patients in open communication about their bowel urgency as part of shared decision-making in order to improve clinical outcomes, and the faculty also review real-world patient cases.

This CME Outfitters Webcast, entitled Clean-Up on IL-23: Integrating the Science of Inflammatory Targets into Treatment Decision-making in IBD, will feature an expert panel discussion on the science behind cytokine-targeting therapies and will utilize animated 3-D models to discuss therapeutic mechanisms of action (MOAs) of emerging agents, clinical distinctions between therapies, and individualizing treatments for lasting outcomes for patients with IBD.

In this CME Outfitters BriefCase, expert Dr. Anita Afzali will utilize case-based learning to illustrate the common features and pathophysiologic mechanisms underlying these two inflammatory disorders. Faculty will translate clinical data to help clinicians to select optimal treatments aimed at improving outcomes for patients impacted by PsO and IBD.

In this CME Outfitters BriefCase, Drs. Peek and Quezada will guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that exist in racial and ethnic underserved patients with IBD.

In this podcast installment of a multi-prong diversity, equity, and inclusion (DEI) series, Monica E. Peek, MD, MPH, MSc; Sophie Balzora, MD, FACG; and Nana Bernasko, CRNP, DNP, WHNP-BC, will discuss strategies vital to combating inequities in IBD.

Dr. Regueiro interviews medical professionals across the various disciplines in the IBD Medical Home at the Cleveland Clinic. This patient-centric treatment model assembles both physical and mental health practitioners at the community level, delivering best practices in prevention, screening and …

This downloadable resource contains useful information on team-based care of patients with short bowel syndrome, focusing on initiating and monitoring advanced pharmacotherapy with glucagon-like peptide-2 (GLP-2) analogs.